Signaling pathways
-
BA2890 INI-43Summary: INI-43 is an inhibitor that interferes with the nuclear localization of Kpnβ1 and known Kpnβ1cargo proteins, NFAT, NFκB, AP-1 and NFY. - BA2891 ArtemisiteneSummary: Artemisitene is a natural derivative of Artemisinin, an activator with antioxidant and anticancer activity.
- BA2892 FOXO4-DRISummary: FOXO4-DRI is a cell-permeable peptide antagonist.
- BA2893 DMU-212Summary: DMU-212 is a resveratrol methylated derivative with antidisintegrative, antiproliferative, antioxidant and apoptosis-promoting activities.
- BA2894 ARS-853Summary: ARS-853 is a selective, covalent inhibitor.
- BA2895 CCT128930Summary: CCT128930 is an ATP-competitive and selective inhibitor (value of 6 nM for AKT2).
- BA2896 MN58bSummary: MN58b is a selective inhibitor of phosphorylcholine synthesis.
- BA2897 AlkanninSummary: Alkannin is a potent and specific inhibitor of tumor-type pyruvate kinase-M2 (PKM2).
- BA2898 LCS3Summary: LCS3 is a reversible and non-competitive inhibitor of glutathione disulfide reductase and thioredoxin reductase 1 (3.3 μM and 3.8 μM, respectively).
- BA2899 MY-1076Summary: MY-1076 is an inhibitor.